{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:40:13Z","timestamp":1758901213393,"version":"3.44.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12325-025-03306-4","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:29:34Z","timestamp":1755109774000},"page":"5124-5133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contralateral Randomized Comparison Between Intracameral Extended-Release Dexamethasone 9% Suspension Placed in the Capsular Bag with the Established Post-Cataract Regimen"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-3623","authenticated-orcid":false,"given":"Vasilios F.","family":"Diakonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George D.","family":"Kymionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos T.","family":"Tsaousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee C.","family":"Bondurant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina G.","family":"Koulotsiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"3306_CR1","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2016.09.027","volume":"124","author":"RJ Olson","year":"2017","unstructured":"Olson RJ, Braga-Mele R, Chen SH, et al. Cataract in the adult eye preferred practice pattern. Ophthalmology. 2017;124:P1\u2013119.","journal-title":"Ophthalmology"},{"key":"3306_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001022","author":"DM Visco","year":"2023","unstructured":"Visco DM. Comparison of post cataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain and photophobia. J Cataract Refract Surg. 2023. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001022.","journal-title":"J Cataract Refract Surg"},{"key":"3306_CR3","unstructured":"EyePoint Pharmaceuticals, Inc. Dexycu (Dexamethasone Intraocular Suspension) 9%: Highlights of prescribing information. Watertown, MA, Eyepoint pharmaceuticals Inc, 2020."},{"key":"3306_CR4","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jcrs.2014.02.037","volume":"40","author":"JA An","year":"2014","unstructured":"An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40:1857\u201361.","journal-title":"J Cataract Refract Surg"},{"key":"3306_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1755-3768.2007.01155.x","volume":"86","author":"TS Dietlein","year":"2008","unstructured":"Dietlein TS, Jordan JF, Luke C, Schild A, Dinslage S, Krieglstein GK. Self-application of single use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol. 2008;86:856\u20139.","journal-title":"Acta Ophthalmol"},{"key":"3306_CR6","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/OPTH.S165722","volume":"12","author":"TJ Shah","year":"2018","unstructured":"Shah TJ, Conway MD, Payman GA. Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy. Clin Ophthalmol. 2018;12:2223\u201335.","journal-title":"Clin Ophthalmol"},{"key":"3306_CR7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/j.jcrs.0000000000000887","volume":"48","author":"JA Hovanesian","year":"2022","unstructured":"Hovanesian JA, Donnenfeld ED. Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery. J Cataract Refract Surg. 2022;48:906\u201311.","journal-title":"J Cataract Refract Surg"},{"key":"3306_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/ICL.0000000000000873","volume":"48","author":"Z Bergman","year":"2022","unstructured":"Bergman Z, Thompson R, Malouf A, Swamy R. Iris atrophy after administration of intracameral Dexycu in routine cataract surgery: a case series. Eye Contact Lens. 2022;48:185\u20137.","journal-title":"Eye Contact Lens"},{"key":"3306_CR9","unstructured":"Evaluate the safety of DEXYCU for the treatment of inflammation following ocular surgery for childhood cataract. ClinicalTrials.gov Identifier NCT05191706. https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT05191706. Accessed Apr 3, 2025.\u200b"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03306-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03306-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03306-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:09:01Z","timestamp":1758899341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03306-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3306"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03306-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Vasilios F. Diakonis MD, PhD, George D. Kymionis MD, PhD, Konstantinos T. Tsaousis MD, MSc, PhD, Renee C. Bondurant, BS, CCRC, Caroline C. Watson, MD, Konstantina G. Koulotsiou, and Robert J. Weinstock MD have nothing to disclose. George D. Kymionis is an Editorial Board member of Ophthalmology and Therapy. George D. Kymionis was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the New England Independent Review Board under approval number 120190444, 2020. Informed consent to participate in this study was obtained from all participants prior to their enrollment. Participants were fully informed about the study\u2019s purpose, procedures, potential risks, the voluntary nature of their participation, and the right to withdraw from the study at any time without any penalty or consequence. The informed consent process ensured that participants understood the study details, including the post-cataract surgery follow-up visits, the medications administered, and the potential risks associated with the study. This study was conducted in accordance with the principles set out in the Declaration of Helsinki (1964) and its subsequent amendments, ensuring that ethical standards were upheld throughout the research.Informed consent for publication was also obtained from all participants. Specifically, this includes consent for the use of anonymized data, images, and photographs collected during the study, as well as any other study-related information, for publication in peer-reviewed journals. Participants were informed that their data would be de-identified, and no personal identifiers would be included in any published materials. They were also made aware that their consent for publication could not be withdrawn after data has been anonymized and submitted for publication. Participants were assured that all reasonable measures would be taken to maintain confidentiality and privacy in accordance with data protection laws. The consent for publication was separate from the consent to participate in the study, and participants had the opportunity to review the consent form and ask questions before providing their written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}